“…al. 18 reported the synthesis, characterization, molecular docking simulation and antitubercular activity of new class of spiropyrrolidine oxindoles, these compounds showed signicant activity against tested Mycobacterium tuberculosis H37R. In addition, to the biological precedents of the spiro compounds described above, most of the spiropyrrolidines reported in the literature demonstrated significant biological activity, including anti-TB activity, 19,20 some of these spiro compounds were even more potent than reference standard.…”